BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27128845)

  • 1. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.
    Abdelsalam A; Rashed L; Salman T; Hammad L; Sabry D
    J Dig Dis; 2016 Aug; 17(8):547-553. PubMed ID: 27128845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.
    Hung CH; Hu TH; Lu SN; Chen CH; Wang JH; Lee CM
    J Formos Med Assoc; 2016 Apr; 115(4):278-83. PubMed ID: 26725771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
    Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
    Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
    El-Derany MO; Hamdy NM; Al-Ansari NL; El-Mesallamy HO
    BMC Gastroenterol; 2016 Feb; 16():19. PubMed ID: 26911666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of Vitamin D Receptor Polymorphisms with Response to Antiviral Therapy in Patients with Chronic Hepatitis C].
    Wang C; Wu Q; Wei XT; Li ZZ; Lei XZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):227-31. PubMed ID: 27263300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.
    Shaker O; Nassar Y; Ayoub S; Elrazki M; Zahra A
    J Clin Lab Anal; 2016 Nov; 30(6):1021-1027. PubMed ID: 27087054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.
    García-Martín E; Agúndez JA; Maestro ML; Suárez A; Vidaurreta M; Martínez C; Fernández-Pérez C; Ortega L; Ladero JM
    PLoS One; 2013; 8(9):e74764. PubMed ID: 24073221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
    Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
    Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.
    Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A
    Pharmacogenet Genomics; 2016 Jun; 26(6):307-10. PubMed ID: 27139837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study.
    Scalioni LP; Santos BRD; Spritzer PM; Villela-Nogueira CA; Laura Lewis-Ximenez L; Pollo-Flores P; Bordalo Cathalá Esberard E; Brandão-Mello CE; Lampe E; Villar LM
    Medicine (Baltimore); 2018 Feb; 97(8):e9881. PubMed ID: 29465575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum levels and receptor genes BsmI, TaqI and FokI polymorphisms of vitamin D with the severity of multiple sclerosis.
    Moosavi E; Rafiei A; Yazdani Y; Eslami M; Saeedi M
    J Clin Neurosci; 2021 Feb; 84():75-81. PubMed ID: 33485603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between vitamin D receptor polymorphisms and systemic lupus erythematosus in an Indian cohort.
    Mahto H; Tripathy R; Das BK; Panda AK
    Int J Rheum Dis; 2018 Feb; 21(2):468-476. PubMed ID: 29230954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
    BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma risk is associated with vitamin D receptor gene polymorphisms.
    Zeljic K; Kandolf-Sekulovic L; Supic G; Pejovic J; Novakovic M; Mijuskovic Z; Magic Z
    Melanoma Res; 2014 Jun; 24(3):273-9. PubMed ID: 24638155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Moczulski D; Klupa T; Kozek E; Sieradzki J
    Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):505-9. PubMed ID: 14714273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Receptor Gene Polymorphisms in Serbian Patients With Bronchial Asthma: A Case-Control Study.
    Despotovic M; Jevtovic Stoimenov T; Stankovic I; Basic J; Pavlovic D
    J Cell Biochem; 2017 Nov; 118(11):3986-3992. PubMed ID: 28407346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Receptor Gene BSMI, FOKI, APAI, and TAQI Polymorphisms and the Risk of Atopic Dermatitis.
    Kılıç S; Sılan F; Hız MM; Işık S; Ögretmen Z; Özdemir Ö
    J Investig Allergol Clin Immunol; 2016; 26(2):106-10. PubMed ID: 27164626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.
    Lange CM; Bibert S; Kutalik Z; Burgisser P; Cerny A; Dufour JF; Geier A; Gerlach TJ; Heim MH; Malinverni R; Negro F; Regenass S; Badenhoop K; Bojunga J; Sarrazin C; Zeuzem S; Müller T; Berg T; Bochud PY; Moradpour D;
    PLoS One; 2012; 7(7):e40159. PubMed ID: 22808108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
    Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
    World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.